Table of Content

1 Study Coverage
1.1 Biologics Product Introduction
1.2 Market by Type
1.2.1 Global Biologics Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Biologics Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Biologics Market by Region
1.4.1 Global Biologics Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Biologics Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Biologics Revenue by Players
2.1.1 Global Biologics Revenue by Players (2019-2024)
2.1.2 Global Biologics Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Biologics Revenue in 2024
2.2 Global Biologics Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Biologics Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Merck
3.1.1 Merck Information
3.1.2 Merck Overview
3.1.3 Merck Biologics Revenue and Gross Margin (2019-2024)
3.1.4 Merck Related Developments
3.2 Johnson & Johnson
3.2.1 Johnson & Johnson Information
3.2.2 Johnson & Johnson Overview
3.2.3 Johnson & Johnson Biologics Revenue and Gross Margin (2019-2024)
3.2.4 Johnson & Johnson Related Developments
3.3 Sanofi
3.3.1 Sanofi Information
3.3.2 Sanofi Overview
3.3.3 Sanofi Biologics Revenue and Gross Margin (2019-2024)
3.3.4 Sanofi Related Developments
3.4 Bristol-Myers Squibb.
3.4.1 Bristol-Myers Squibb. Information
3.4.2 Bristol-Myers Squibb. Overview
3.4.3 Bristol-Myers Squibb. Biologics Revenue and Gross Margin (2019-2024)
3.4.4 Bristol-Myers Squibb. Related Developments
3.5 Catalent
3.5.1 Catalent Information
3.5.2 Catalent Overview
3.5.3 Catalent Biologics Revenue and Gross Margin (2019-2024)
3.5.4 Catalent Related Developments
3.6 AbbVie
3.6.1 AbbVie Information
3.6.2 AbbVie Overview
3.6.3 AbbVie Biologics Revenue and Gross Margin (2019-2024)
3.6.4 AbbVie Related Developments
3.7 Takeda
3.7.1 Takeda Information
3.7.2 Takeda Overview
3.7.3 Takeda Biologics Revenue and Gross Margin (2019-2024)
3.7.4 Takeda Related Developments
3.8 Novartis
3.8.1 Novartis Information
3.8.2 Novartis Overview
3.8.3 Novartis Biologics Revenue and Gross Margin (2019-2024)
3.8.4 Novartis Related Developments
4 Global Biologics Market Insights
4.1 Global Biologics Market Revenue 2019-2024
4.2 Global Biologics Revenue by Region
4.3 Americas
4.4 Europe
4.5 Asia-Pacific
4.6 Middle East & Africa
5 Market Size by Type
5.1 Global Biologics Revenue by Type
5.2 Global Biologics Market Size Growth by Type 2019-2024
6 Market Size by Application
6.1 Global Biologics Revenue by Application
6.2 Global Biologics Market Size Growth by Application 2019-2024
7 Americas
7.1 Americas Biologics Market Size by Type
7.1.1 Americas Biologics Revenue by Type (2019-2024)
7.1.2 Americas Biologics Revenue Share by Type (2019-2024)
7.2 Americas Biologics Market Size by Application
7.2.1 Americas Biologics Revenue by Application (2019-2024)
7.2.2 Americas Biologics Revenue Share by Application (2019-2024)
7.3 Americas Biologics Market Size by Country
7.3.1 Americas Biologics Revenue by Country (2019-2024)
7.3.2 U.S.
7.3.3 Canada
7.3.4 Mexico
7.3.5 Brazil
7.3.6 Argentina
8 Europe
8.1 Europe Biologics Market Size by Type
8.1.1 Europe Biologics Revenue by Type (2019-2024)
8.1.2 Europe Biologics Revenue Share by Type (2019-2024)
8.2 Europe Biologics Market Size by Application
8.2.1 Europe Biologics Revenue by Application (2019-2024)
8.2.2 Europe Biologics Revenue Share by Application (2019-2024)
8.3 Europe Biologics Market Size by Country
8.3.1 Europe Biologics Revenue by Country (2019-2024)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
9 Asia Pacific
9.1 Asia Pacific Biologics Market Size by Type
9.1.1 Asia Pacific Biologics Revenue by Type (2019-2024)
9.1.2 Asia Pacific Biologics Revenue Share by Type (2019-2024)
9.2 Asia Pacific Biologics Market Size by Application
9.2.1 Asia Pacific Biologics Revenue by Application (2019-2024)
9.2.2 Asia Pacific Biologics Revenue Share by Application (2019-2024)
9.3 Asia Pacific Biologics Market Size by Region
9.3.1 Asia Pacific Biologics Revenue by Region (2019-2024)
9.3.2 China
9.3.3 Japan
9.3.4 South Korea
9.3.5 India
9.3.6 Southeast Asia
9.3.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Biologics Market Size by Type
10.1.1 Middle East and Africa Biologics Revenue by Type (2019-2024)
10.1.2 Middle East and Africa Biologics Revenue Share by Type (2019-2024)
10.2 Middle East and Africa Biologics Market Size by Application
10.2.1 Middle East and Africa Biologics Revenue by Application (2019-2024)
10.2.2 Middle East and Africa Biologics Revenue Share by Application (2019-2024)
10.3 Middle East and Africa Biologics Market Size by Country
10.3.1 Middle East and Africa Biologics Revenue by Country (2019-2024)
10.3.2 Turkey
10.3.3 Saudi Arabia
10.3.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Biologics Industry Trends
11.2 Biologics Market Drivers
11.3 Biologics Market Challenges
11.4 Biologics Market Restraints
12 Biologics Forecasted Market Size by Type
12.1 Global Biologics Forecasted Revenue by Type
12.2 Global Biologics Forecasted Market Size Growth by Type 2024-2030
13 Biologics Forecasted Market Size by Application
13.1 Global Biologics Forecasted Revenue by Application
13.2 Global Biologics Forecasted Market Size Growth by Application 2024-2030
14 Global Biologics Market Forecasts
14.1 Global Biologics Market Revenue Forecasts 2024-2030
14.2 Global Biologics Forecasts Revenue by Region
14.3 Americas
14.4 Europe
14.5 Asia-Pacific
14.6 Middle East & Africa
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer